# A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

> **NCT01138072** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 14 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus

## Interventions

- **DRUG:** GSK2248761
- **DRUG:** Simvastatin
- **DRUG:** Atorvastatin
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01138072
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2010-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01138072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01138072, "A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01138072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*